Abstract Glucagon-like peptide 1 (GLP-1) receptor agonists are widely used for glycemic
control in patients with diabetes mellitus (DM) and are primarily indicated for type 2 diabetes …

Abstrat Glucagon-like peptide 1 (GLP-1) is a hormone of the incretin family, secreted in
response to nutrient ingestion, and plays a role in metabolic homeostasis. GLP-1 receptor …

Background: Previous findings on using Glucagon-like peptide-1 receptor agonist (GLP1-
RA) as an antidepressant were conflicting, lacking large-scale studies. We used population …

Aims/introduction Cognitive dysfunction, including mild cognitive impairment and dementia,
is increasingly recognized as an important complication of type 2 diabetes mellitus. The …

Background: Obesity is a chronic disease associated with increased morbidity and mortality
due to its complications. The aims of obesity treatment are primarily to accomplish weight …

Obesity is a critical health condition worldwide that increases the risks of comorbid chronic
diseases, but it can be managed with weight loss. However, conventional interventions …

Obesity and mental illness are commonly encountered clinical issues that nurse
practitioners manage. A bidirectional and complex relationship exists between these 2 …

Background: Obesity is a chronic disease associated with increased morbidity and mortality
due to its complications. The aims of obesity treatment are primarily to accomplish weight …